Year: 2022

btt Corp. Raises $29.3 Million to Deploy Diagnostic and Treatment Technologies Based on Brain Thermodynamics and Thermoregulatory Frequencies

World’s only brain-guided heat shock protein induction could help millions affected with neurologic disorders AVENTURA, Fla.--(BUSINESS WIRE)--btt Corp. (btt), a...

iTolerance, Inc. Awarded Industry Discovery and Development Partnership with JDRF for Advanced Pre-Clinical Development of iTOL-100 and iTOL-101 for the Treatment of Type 1 Diabetes

Company advancing development of lead program, iTOL-101, as a potential breakthrough in curing Type 1 Diabetes with the potential to...

error: Content is protected !!